Forbes August 19, 2024
Dr. Sai Balasubramanian, M.D., J.D.

Famed international pharmacy chain Walgreens is contemplating selling one of its most celebrated acquisitions— VillageMD, a value based primary care service the company acquired in 2021 for nearly $5.2 billion. Unfortunately, generating a profit from this acquisition has not been easy for the company, especially with growing economic headwinds, significant changes in pharmaceutical demand after the Covid-19 pandemic and an overall tumultuous business environment. Last year, the company announced that it would be closing nearly 60 under-performing clinics as part of an effort to save nearly $1 billion dollars. At that time, Walgreens explained that it was impacted by lower than expected consumer spending as among the primary reasons for a poor earnings outlook.

Since then, the company has continued...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Primary care, Provider, Trends
Healthcare supply chain, pharmacy costs to rise in 2025: report
STAT+: DeepSeek signals China’s rising influence in AI — and AI drug development
Is 2025 the Chinese Year of BioPharma?
Pharma Pulse 2/3/25: The Rundown on Rebates, GLP-1s and Pharmacists' Role & more
Inflation Reduction Act Unintended Consequences For Medical Innovation

Share This Article